Cargando…
Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma
KRAS mutation testing is mandatory before prescribing anti-epidermal growth factor monoclonal antibodies in the treatment of advanced colorectal cancer. We describe the performance of a TaqMelt polymerase chain reaction (PCR) assay—the cobas® KRAS Mutation Test—designed to detect 19 mutations in cod...
Autores principales: | Lee, Sung, Brophy, Victoria H., Cao, Jianli, Velez, Margot, Hoeppner, Corey, Soviero, Stephen, Lawrence, H. Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303066/ https://www.ncbi.nlm.nih.gov/pubmed/22173329 http://dx.doi.org/10.1007/s00428-011-1180-0 |
Ejemplares similares
-
KRAS Mutation Detection in Paired Frozen and Formalin-Fixed Paraffin-Embedded (FFPE) Colorectal Cancer Tissues
por: Solassol, Jérome, et al.
Publicado: (2011) -
Performance of a novel KRAS mutation assay for formalin-fixed paraffin embedded tissues of colorectal cancer
por: Sakai, Kazuko, et al.
Publicado: (2015) -
Massively parallel sequencing of formalin-fixed paraffin-embedded tissues
por: Erlich, Rachel L, et al.
Publicado: (2012) -
Virus characterization and discovery in formalin-fixed paraffin-embedded tissues
por: Bodewes, Rogier, et al.
Publicado: (2015) -
Profiling chromatin accessibility in formalin-fixed paraffin-embedded samples
por: Zhang, Hua, et al.
Publicado: (2022)